Sunnyvale, Calif.-based CRO ProTrials Research has created a wholly owned subsidiary to help meet its sponsors’ increasing needs for multi-national, multi-site clinical trials. Based in the United Kingdom, ProTrials Global will help manage ongoing clinical trials in Italy, Spain and the U.K., and will be responsible for additional growth in the European arena.
Gillian Reid, the company’s newly appointed director of business operations, Europe, will manage ProTrials Global. With more than 25 years of clinical research experience, Reid previously worked for Charles River Laboratories, Inveresk Research, Napp Laboratories and Merck Sharp & Dohme. Most recently, she was the director of global key accounts for Chiltern International UK.
“With ProTrials Global based in the U.K., we are in a stronger position to help sponsors simultaneously conduct clinical trials in North America and Europe, and to guide them in the different complexities for conducting clinical research abroad,” said Jodi Andrews, co-founder and CEO of ProTrials.
Founded in 1996, ProTrials Research is a specialized CRO with regional clinical research associates and project managers based throughout North America, Canada and Europe. It provides site monitoring, project management and associated clinical operations services.